Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: Vallon Pharmaceuticals, Inc. (0) Acquired (1)
gri-0621 (1 trial)
amphetamine (Adderall) (1 trial)
dextroamphetamine (Dexedrine) (1 trial)
Narcolepsy (Phase 1)
Trials (3 total)
Trial APIs (3 total)